Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Mar;36(3):662–664. doi: 10.1128/aac.36.3.662

Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

M Reig 1, A Moreno 1, F Baquero 1
PMCID: PMC190575  PMID: 1622181

Abstract

The activities of erythromycin and clindamycin against 350 Peptostreptococcus strains were studied during a 5-year period (1986 to 1991). In 5.1% of the Peptostreptococcus strains, which presented dissociated resistance (clindamycin MIC, less than or equal to 1 microgram/ml; erythromycin MIC, greater than 8 micrograms/ml), evidence of inducible macrolide-lincosamide resistance was shown. A total of 17.7% of the strains presented a constitutive phenotype; the clindamycin and erythromycin MICs for these strains were greater than 8 micrograms/ml.

Full text

PDF
662

Images in this article

663Image
on p.663

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dubreuil L., Devos J., Neut C., Romond C. Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics. Antimicrob Agents Chemother. 1984 Jun;25(6):764–766. doi: 10.1128/aac.25.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hill G. B., Ayers O. M. Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections. Antimicrob Agents Chemother. 1985 Mar;27(3):324–331. doi: 10.1128/aac.27.3.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Horinouchi S., Weisblum B. The control region for erythromycin resistance: free energy changes related to induction and mutation to constitutive expression. Mol Gen Genet. 1981;182(2):341–348. doi: 10.1007/BF00269681. [DOI] [PubMed] [Google Scholar]
  4. Nord C. E., Lindmark A., Person I. Susceptibility of anaerobic bacteria to FCE 22101. Antimicrob Agents Chemother. 1987 May;31(5):831–833. doi: 10.1128/aac.31.5.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ohm-Smith M. J., Sweet R. L., Hadley W. K. Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy. Antimicrob Agents Chemother. 1986 Jul;30(1):11–14. doi: 10.1128/aac.30.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ohm-Smith M. J., Sweet R. L. In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections. Antimicrob Agents Chemother. 1987 Sep;31(9):1434–1437. doi: 10.1128/aac.31.9.1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Reig M., Baquero F. Selection of constitutively resistant mutants of inducible clindamycin-resistant Bacteroides vulgatus. Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):711–715. doi: 10.1007/BF01963757. [DOI] [PubMed] [Google Scholar]
  8. Sutter V. L., Finegold S. M. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother. 1976 Oct;10(4):736–752. doi: 10.1128/aac.10.4.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Weisblum B., Siddhikol C., Lai C. J., Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. J Bacteriol. 1971 Jun;106(3):835–847. doi: 10.1128/jb.106.3.835-847.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wexler H. M., Finegold S. M. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother. 1988 Mar;32(3):403–406. doi: 10.1128/aac.32.3.403. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES